-
- EXPLORER
-
-
-
-
-
-
Mises à jour récentes
-
Protheragen Launches Specialized Services to Support Research on Systemic Mitochondrial DiseaseProtheragen, a leading biotechnology company specializing in advanced research services, announces its comprehensive suite of solutions designed to accelerate research and treatment development for Systemic Mitochondrial Disease. The company’s specialized services address the complex challenges associated with these rare but devastating disorders. Systemic Mitochondrial Disease...0 Commentaires 0 Parts 212 Vue 0 AperçuConnectez-vous pour aimer, partager et commenter!
-
Protheragen Advances Gene Therapy Research with Adeno-Associated Virus (AAV) Vector PlatformProtheragen, a leading biotechnology company specializing in innovative genetic solutions, announced the expansion of its comprehensive Adeno-Associated Virus (AAV) Vector Platform services to meet the growing demands of gene therapy research and development. Adeno-associated virus (AAV) is a non-enveloped virus that can transport DNA to target cells through genetic engineering, and it has...0 Commentaires 0 Parts 210 Vue 0 Aperçu
-
0 Commentaires 0 Parts 25 Vue 0 Aperçu
Plus de lecture